A public company • NEO: MMED OTC: MMEDF
Eight Capital
Velos Partners
Noetic Psychedelic Fund
Seven Hound Ventures
Explorer Equity Group
JLS Fund
BTG Capital
Carol Nast
Chief Operating Officer
Collin Gage
Head of Corporate Development
Dave Guebert
Chief Financial Officer
Donald Gehlert
Chief Scientific Officer
Jeanne Bonelle
EVP, Technical Operations
JR Rahn
Co-Founder, Director & Co-CEO
Madeline Feldman
Director of Operations & Administration
Nico Forte
Chief Of Staff, Senior Director, Business Operations and Development
Scott Freeman
Co-Founder, Chief Medical Officer
Stephen L. Hurst
Co-Founder, Executive Chair & Co-CEO
Robert Barrow
CEO
Psychedelic Capital
Jul 30, 2020
Limina Foundation
Mr. Psychedelic Law
XPhyto
CURE Pharmaceutical
Mycrodose Therapeutics
Society for Psychedelic Outreach Reform and Education (SPORE)